Afzelin exhibits anti-cancer activity against androgen-sensitive LNCaP and androgen-independent PC-3 prostate cancer cells through the inhibition of LIM domain kinase 1

Author:                  

Publisher: Spandidos Publications

E-ISSN: 1792-1082|10|4|2359-2365

ISSN: 1792-1074

Source: Oncology Letters, Vol.10, Iss.4, 2015-01, pp. : 2359-2365

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content